UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.044

Sortiert nach

Pathogenicity and virulence of Yersinia

Virulence, 2024-12, Vol.15 (1), p.2316439-2316439

2024

Link zum Volltext

Verfügbarkeit prüfen

Shift from primary pneumonic to secondary septicemic plague by decreasing the volume of intranasal challenge with Yersinia pestis in the murine model

PloS one, 2019-05, Vol.14 (5), p.e0217440-e0217440

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product

PloS one, 2019-11, Vol.14 (11), p.e0224700

2019

Link zum Volltext

Verfügbarkeit prüfen

Integrative analysis highlights molecular and immune responses of tick Amblyomma americanum to Escherichia coli challenge

Frontiers in cellular and infection microbiology, 2023-07, Vol.13, p.1236785-1236785

2023

Link zum Volltext

Verfügbarkeit prüfen

Equine Polyclonal Antibodies Prevent Acute Chikungunya Virus Infection in Mice

Viruses, 2023-06, Vol.15 (7), p.1479

2023

Link zum Volltext

Verfügbarkeit prüfen

Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT ® ) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review

Toxins, 2021-12, Vol.14 (1), p.19

2021

Link zum Volltext

Verfügbarkeit prüfen

Absence of Inflammation and Pneumonia during Infection with Nonpigmented Yersinia pestis Reveals a New Role for the pgm Locus in Pathogenesis

Infection and Immunity, 2010-01, Vol.78 (1), p.220-230

2010

Link zum Volltext

Verfügbarkeit prüfen

Resistance to Innate Immunity Contributes to Colonization of the Insect Gut by Yersinia pestis

PloS one, 2015-07, Vol.10 (7), p.e0133318-e0133318

2015

Link zum Volltext

Verfügbarkeit prüfen

Opposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plague

PLoS pathogens, 2012-07, Vol.8 (7), p.e1002817-e1002817

2012

Link zum Volltext

Verfügbarkeit prüfen

Imaging early pathogenesis of bubonic plague: are neutrophils commandeered for lymphatic transport of bacteria?

mBio, 2013-11, Vol.4 (6), p.e00837-e00813

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States

Clinical infectious diseases, 2020-04, Vol.70 (9), p.1950-1957

2020

Link zum Volltext

Verfügbarkeit prüfen

Dual-Function Antibodies to Yersinia pestis LcrV Required for Pulmonary Clearance of Plague

Clinical and Vaccine Immunology, 2009-12, Vol.16 (12), p.1720-1727

2009

Link zum Volltext

Verfügbarkeit prüfen

Protection Induced by Oral Vaccination with a Recombinant Yersinia pseudotuberculosis Delivering Yersinia pestis LcrV and F1 Antigens in Mice and Rats against Pneumonic Plague

Infection and immunity, 2022-08, Vol.90 (8), p.e0016522-e0016522

2022

Link zum Volltext

Verfügbarkeit prüfen

Host Defense and the Airway Epithelium: Frontline Responses That Protect against Bacterial Invasion and Pneumonia

Journal of pathogens, 2011-01, Vol.2011, p.249802-16

2011

Link zum Volltext

Verfügbarkeit prüfen

Novel genetic tools for diaminopimelic acid selection in virulence studies of Yersinia pestis

PloS one, 2011-03, Vol.6 (3), p.e17352

2011

Link zum Volltext

Verfügbarkeit prüfen

Expression hierarchy in the Yersinia type III secretion system established through YopD recognition of RNA

Molecular microbiology, 2011-05, Vol.80 (4), p.966-980

2011

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and Protective Immunity against Bubonic Plague and Pneumonic Plague by Immunization of Mice with the Recombinant V10 Antigen, a Variant of LcrV

Infection and Immunity, 2006-08, Vol.74 (8), p.4910-4914

2006

Link zum Volltext

Verfügbarkeit prüfen

Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study

Antimicrobial agents and chemotherapy, 2023-03, Vol.67 (3), p.e0151422-e0151422

2023

Link zum Volltext

Verfügbarkeit prüfen

Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection

Infection and immunity, 2017-11, Vol.85 (11)

2017

Link zum Volltext

Verfügbarkeit prüfen

Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of Yersinia pestis

Antimicrobial agents and chemotherapy, 2020-03, Vol.64 (4)

2020

Link zum Volltext

Verfügbarkeit prüfen

Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague

Infection and immunity, 2019-04, Vol.87 (4)

2019

Link zum Volltext

Verfügbarkeit prüfen

Results of a Double-Blind, Randomized, Placebo-Controlled Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Anti-Zika Virus Immunoglobulin

The American journal of tropical medicine and hygiene, 2021-12, Vol.105 (6), p.1552-1562

2021

Link zum Volltext

Verfügbarkeit prüfen

Interrelationship of soil moisture and temperature to sylvatic plague cycle among prairie dogs in the Western United States

Integrative zoology, 2021-11, Vol.16 (6), p.852-867

2021

Link zum Volltext

Verfügbarkeit prüfen

Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague

Infection and immunity, 2021-02, Vol.89 (3)

2021

Link zum Volltext

Verfügbarkeit prüfen

YopD and LcrH Regulate Expression of Yersinia enterocolitica YopQ by a Posttranscriptional Mechanism and Bind to yopQ RNA

Journal of Bacteriology, 2002-03, Vol.184 (5), p.1287-1295

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.044

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(959)
Mit Volltextzugriff
(913)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Pathogenicity and virulence of Yersinia

Shift from primary pneumonic to secondary septicemic plague by decreasing the volume of intranasal challenge with Yersinia pestis in the murine model

Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product

Integrative analysis highlights molecular and immune responses of tick Amblyomma americanum to Escherichia coli challenge

Equine Polyclonal Antibodies Prevent Acute Chikungunya Virus Infection in Mice

Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT ® ) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review

Absence of Inflammation and Pneumonia during Infection with Nonpigmented Yersinia pestis Reveals a New Role for the pgm Locus in Pathogenesis

Resistance to Innate Immunity Contributes to Colonization of the Insect Gut by Yersinia pestis

Opposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plague

Imaging early pathogenesis of bubonic plague: are neutrophils commandeered for lymphatic transport of bacteria?

Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States

Dual-Function Antibodies to Yersinia pestis LcrV Required for Pulmonary Clearance of Plague

Protection Induced by Oral Vaccination with a Recombinant Yersinia pseudotuberculosis Delivering Yersinia pestis LcrV and F1 Antigens in Mice and Rats against Pneumonic Plague

Host Defense and the Airway Epithelium: Frontline Responses That Protect against Bacterial Invasion and Pneumonia

Novel genetic tools for diaminopimelic acid selection in virulence studies of Yersinia pestis

Expression hierarchy in the Yersinia type III secretion system established through YopD recognition of RNA

Immunogenicity and Protective Immunity against Bubonic Plague and Pneumonic Plague by Immunization of Mice with the Recombinant V10 Antigen, a Variant of LcrV

Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study

Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection

Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of Yersinia pestis

Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague

Results of a Double-Blind, Randomized, Placebo-Controlled Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Anti-Zika Virus Immunoglobulin

Interrelationship of soil moisture and temperature to sylvatic plague cycle among prairie dogs in the Western United States

Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague

YopD and LcrH Regulate Expression of Yersinia enterocolitica YopQ by a Posttranscriptional Mechanism and Bind to yopQ RNA

Suchergebnisse filtern